(PharmaNewsWire.Com, February 23, 2017 ) Europe Liquid Biopsy market is expected to increase at a CAGR of 21.45% in the forecast period of 2016-2021 and reach a value of USD 358.69 million by 2021 from USD 135.75 million in 2016.
Europe region is also showing high growth in liquid biopsy in future. Increase in population, patients suffering from cancer, increasing awareness within the people, and the need to detect and recover cancer are some factors driving the market. Lung cancer is one of the most common diseases in European countries. European market is geographically segmented into UK, France, Italy, Germany and Spain. Technological advances over the past two decades are starting to change by flagging the way for liquid biopsy. Liquid biopsies also present with a unique opportunity to move forward with the understanding of metastatic disease development, especially to identify the pathways involved in cell invasiveness and metastatic competence.
Use of liquid biopsies is rapidly increasing as it has attracted the researchers and life sciences companies, as evidence mounts that a simple blood draw is now able to reveal whether a therapy has actually worked or not. Early stage detection of cancer is now possible with the technique of liquid biopsies. This could lead to establishment of a longer treatment and healthier chances of extending the survival period of the patient.
The liquid biopsy market is mainly segmented by types of cancer into Lung Cancer, Pancreatic Cancer, Leukemia and Other Visceral Cancers. By Diagnostic approach they can be classified as Circulating Tumour cells (CTC), Circulating Tumour DNA (ctDNA), RNA in exosomes and Extra-Cellular Vesicles. Based on end users, the market is segmented into reference laboratories, hospital/physician laboratories, academic and research centers, and other end users. The market is bifurcate into blood, urine, plasma, saliva and Cerebrospinal fluid based upon sample type. CTCs (Circulating Tumour cells), the first such entities on the liquid biopsy scene, have accounted for a large share in the market. Cancer institute is the largest end user segment in terms of revenues and is expected to create substantial opportunity in global liquid biopsy market over the forecast period.
The Liquid Biopsy Market study offers the following deliverables:
Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development.
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
Checkout related reports in the Diagnostic Category:
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: